BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33639045)

  • 1. Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study.
    Solmaz I; Ozdemir MA; Unal E; Abdurrezzak U; Muhtaroglu S; Karakukcu M
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):441-447. PubMed ID: 33639045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of systemic vitamin k2 and vitamin d3 on gingival inflammation and alveolar bone in rats with experimentally induced periodontitis.
    Aral K; Alkan BA; Saraymen R; Yay A; Şen A; Önder GÖ
    J Periodontol; 2015 May; 86(5):666-73. PubMed ID: 25569194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPG/RANK/RANKL Axis in Egyptian Children With Acute Lymphoblastic Leukemia After Maintenance Therapy: Relationship to Bone Mineral and Vitamin D Status.
    Hablas NM; Keshk WA
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e733-e738. PubMed ID: 37494610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts.
    Sanguineti R; Monacelli F; Parodi A; Furfaro AL; Borghi R; Pacini D; Pronzato MA; Odetti P; Molfetta L; Traverso N
    J Biol Regul Homeost Agents; 2016; 30(3):713-726. PubMed ID: 27655488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K; Fukasawa H; Fujigaki Y; Hishida A
    Am J Kidney Dis; 2004 Jan; 43(1):53-60. PubMed ID: 14712427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
    J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.
    Zheng H; Qi S; Chen C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30235836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
    J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
    Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis.
    Stuss M; Rieske P; Cegłowska A; Stêpień-Kłos W; Liberski PP; Brzeziańska E; Sewerynek E
    J Clin Endocrinol Metab; 2013 May; 98(5):E1007-11. PubMed ID: 23543663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.
    Atkinson SA; Fraher L; Gundberg CM; Andrew M; Pai M; Barr RD
    J Pediatr; 1989 May; 114(5):793-800. PubMed ID: 2785592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Ichimura S
    Keio J Med; 2003 Sep; 52(3):147-50. PubMed ID: 14529146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures.
    Maria S; Swanson MH; Enderby LT; D'Amico F; Enderby B; Samsonraj RM; Dudakovic A; van Wijnen AJ; Witt-Enderby PA
    Aging (Albany NY); 2017 Jan; 9(1):256-285. PubMed ID: 28130552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
    Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of vitamin K2 and calcitriol combination on thalassemic osteopathy.
    Ozdemir MA; Yilmaz K; Abdulrezzak U; Muhtaroglu S; Patiroglu T; Karakukcu M; Unal E
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):623-7. PubMed ID: 24136015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of vitamin K2 on osteoporosis in adults with cerebral palsy.
    Kodama Y; Okamoto Y; Kubota T; Hiroyama Y; Fukami H; Matsushita K; Kawano Y
    Brain Dev; 2017 Nov; 39(10):846-850. PubMed ID: 28624135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.